1-[(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]piperidine(CAS: 582300-11-6)

1-[(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]piperidine has a crystalline form with a molecular weight of approximately 754.84 g/mol. It has low solubility in water but is soluble in organic solvents like chloroform and acetone. The compound exhibits high reactivity towards nucleophiles and exhibits good stability towards heat and light.

1-[(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]piperidine is synthesized through multi-step organic synthesis involving the use of phosphorus reagents and piperidine derivatives. The synthesis requires precise control of temperature and reaction time to achieve high yield and selectivity.

1-[(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]piperidine is primarily used in the pharmaceutical industry for developing novel drug candidates. It also finds applications in the semiconductor industry for organic electronic devices and in the polymer industry for developing advanced materials.

Proper handling of 1-[(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]piperidine involves the use of personal protective equipment (PPE), including gloves, safety goggles, and lab coats. It should be stored in a well-ventilated area and away from direct sunlight. Handling should be conducted in a fume hood to minimize inhalation risk. In case of spill, immediate action should be taken following the Material Safety Data Sheet (MSDS) guidelines.